NEXIUM receives approval in Japan for prevention of recurrence of gastric ulcer and duodenal ulcer in patients treated with aspirin at low doses

NEXIUM receives approval in Japan for prevention of recurrence of gastric ulcer and duodenal ulcer in patients treated with aspirin at low doses

Tokyo, Japan (June 22, 2012) -- Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) and AstraZeneca KK (hereafter, AstraZeneca) today announced that AstraZeneca  Read more